Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

Area of Science:

• Neuroimaging
• Biomarkers
• Oncology

Background:

• Functional diffusion maps (fDMs) are increasingly used in neuro-oncology.
• Understanding the biological underpinnings of fDM parameters is crucial for accurate interpretation.
• Gliomas exhibit varying cellularity, impacting imaging characteristics.

Purpose of the Study:

• To rigorously examine the assumptions inherent in functional diffusion map (fDM) analyses.
• To establish a robust biological foundation for the classification capabilities of fDMs.
• To validate fDMs as biomarkers for brain tumor cellularity.

Main Methods:

• Correlation of stereotactic biopsy-derived cell density with preoperative apparent diffusion coefficient (ADC) maps in 69 glioma patients.
• Analysis of 95% confidence intervals for voxel-wise ADC changes in normal-appearing brain tissue to define ADC thresholds for fDMs.
• Assessment of sensitivity and specificity for predicting disease progression using radiographic and neurological criteria.

Main Results:

• Apparent diffusion coefficients (ADCs) demonstrate an inverse relationship with tumor cell density.
• Established 95% confidence intervals for ADC thresholds in various brain tissue compositions.
• fDM classification using these thresholds showed significant sensitivity and specificity for disease progression detection, outperforming chance.

Conclusions:

• Functional diffusion maps (fDMs) are validated as reliable biomarkers for assessing brain tumor cellularity.
• The study provides a biological basis for fDM interpretation in glioma patients.
• fDMs offer a promising non-invasive method for monitoring tumor characteristics and progression.